The expansion of Oreochromis niloticus (Nile tilapia) aquaculture has been increasingly constrained by emerging bacterial diseases. This study reports confirmed an outbreak of Aeromonas dhakensis infection in farmed Nile tilapia, isolated from a commercial farm in Huazhou, Guangdong, China. The dominant strain, designated C246399, was systematically characterized through integrated physiological–biochemical assays, transmission electron microscopy, and molecular phylogenetics based on 16S rRNA and gyrB gene sequencing. Infected fish exhibited clinical signs including perioral swelling, cloacal inflammation, abdominal distension, and ascites. Histopathological analysis revealed severe inflammatory infiltration, tissue necrosis, and hemorrhage in the liver, spleen, and head kidney. Pathogenicity evaluation demonstrated strong β‐hemolytic activity and exceptional resistance to tilapia serum bactericidal effects (survival rate 226.29%), alongside marked virulence in murine serum. Experimental infection fulfilled Koch’s postulates, with a calculated median lethal dose (LD₅₀) of 4.34 × 10⁵ CFU/mL, confirming high pathogenicity. Antimicrobial susceptibility testing against 33 antibiotics showed resistance to 10 agents–including penicillin, ampicillin, and vancomycin–intermediate sensitivity to erythromycin and aminoglycosides, and high sensitivity to third‐generation cephalosporins, fluoroquinolones, and florfenicol. These findings establish A. dhakensis as a novel, highly virulent pathogen in tilapia aquaculture and provide a scientific basis for disease surveillance, antimicrobial stewardship, and targeted control strategies in freshwater farming systems.